The follow up period used to examine outcomes irrespective of ongoing use of the medication (emulating a modified intention-to-treat analysis of a clinical trial), started from the index date, and continued until study end (October 30, 2021), death, or initiation of a GLP1-RA in the DPP4i group, whichever came first (Fig
However, as the medication became more widely used for weight management, more patients began sharing their experiences with dry mouth and a constant need for fluids
Include Units: On your claim form, remember to include the number of units alongside the J-code
Sakura, thng hiu ni ting trong lnh vc chm sc sc khe v lm p, to ra mt gii php ton din cho ln da khe mnh v rng r
To verify your coverage: (1) Log into anthem.com or the Sydney Health app and review your pharmacy and medical benefits for obesity treatment